Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-511346-39-00

Acronym

RAY903CT

Enrollment

Registered

2025-02-11

Start date

2025-03-28

Completion date

Unknown

Last updated

2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antiphospholipid syndrome, Behçet’s Syndrome, Bullous pemphigoid, Dermatomyositis, Immune-mediated necrotizing myopathy, Immune Thrombocytopenia

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria, Bulgaria, Croatia, Czechia, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Romania, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026